Research Research projects Inhibitors of the SARS-CoV-2 / Therapeutics for dengue fever / Bicyclic peptides Infectious viruses such as dengue, Zika, West Nile, Chikungunya or SARS-CoV-2 have common Achilles heel: their protease. Proteases are key enzymes of viral replication and promising drug targets. The project explores constrained peptides targeting proteases available in our lab from flavi-, alpha- and coronaviruses school Student intakeThis project is open for Honours and PhD students group Group Groups Chemical Biology Nitsche Group label Research theme Research themes Medicinal Chemistry and Drug Development Organic chemistry traffic Project status Project status Current Contact contact_support Contact Contact name Dr. Christoph Nitsche Contact email christoph.nitsche@anu.edu.au Content navigation toc About Inhibitors of the SARS-CoV-2 main protease Boronic acids as potential therapeutics for dengue fever Biocompatible synthesis of bicyclic peptides / Genetically encoded bicyclic peptides Genetically encoded bicyclic peptides
